| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10745568 | Parkinsonism & Related Disorders | 2014 | 4 Pages |
Abstract
At ISI 100 R2-BRrc distinguished patients participants with de novo tPD from those with rET with a sensitivity, specificity and accuracy of 100%. Our findings demonstrate the usefulness of BRrc for differentiating de novo tPD from rET.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
R. Nisticò, M. Salsone, B. Vescio, M. Morelli, M. Trotta, G. Barbagallo, G. Arabia, A. Quattrone,